Anhydrosafflor Yellow B alleviates brain injury of acute permanent cerebral ischemia in rats by anti-inflammatory mechanism
Lijuan Song,Qing Wang,Zhi Chai,Ce Zhang,Jing Wang,Jingping Ma,Junhong Guo,Jiezhong Yu,Baoguo Xiao,Guangyuan Han,Jianjun Huang,Cungen Ma
DOI: https://doi.org/10.1080/26895293.2020.1750492
IF: 1.044
2020-01-01
All Life
Abstract:Anhydrosafflor Yellow B (AHSYB), is an effective ingredient with a high content extracted from safflower. The effect of hydroxysafflor yellow A (HSYA), one of the main compounds in safflower, has been extensively investigated both in experimental study and in clinical practice. However, few studies of AHSYB on inflammation in rats with acute permanent cerebral ischemia was explored. In this study, three doses of AHSYB (1.75, 3.5, 7 mg/kg) were administered to rats. The results showed that AHSYB improved neurological deficit, reduced brain infarct volume, alleviated the brain inflammation and suppressed the elevation of both mRNA and protein levels of heat shock protein 60 (HSP60), toll-like receptor 4 (TLR-4), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α). In addition, AHSYB treatment decreased NF-κB p65. All the above effects of AHSYB were more obvious at the dosage of 7 mg/kg. These findings suggest that AHSYB effectively alleviates brain injury followed by acute permanent cerebral ischemia in rats by anti-inflammatory mechanism.
multidisciplinary sciences